Genes regulated by NRF2, XBP1, PPARA or PPARG that are down- or up- regulated in liver of <i>Fmo5</i>^<i>-/-</i> mice compared with WT mice. by Ian R. Phillips (5074121)

Fractions of interaction mechanisms of 100 keV photons for (a) coherent scattering, (b) incoherent scattering and (c) photoelectric interaction. by Mehrdad Shahmohammadi Beni (796228)

Translation of Rot and Protein A is decreased in the absence of ClpX. by Lotte Jelsbak (168171)

CD43^-/- septic mice exhibit decreased frequencies of apoptotic CD8⁺ T_EM as compared to WT septic mice. by Katherine T. Fay (2576998)

“…D) There was a significant decrease in apoptosis of CD44^HI CD62L^LO CD8⁺ T_EM in CD43^-/- septic mice compared to WT septic mice (10.3±1.1 vs 17.9±1.9, p = 0.006). …”

BMDM were infected with <i>L.infantum</i> (LEM3323 WT^PpyRE9/DsRed) for 24 hours followed by treatment with 250 μM PMM or 7.5 μM MIL for 72 hours. by Laura Dirkx (8950205)

Data Sheet 1_Semaglutide attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis of cardiomyocytes via activation of PKC-S100A9 axis.pdf by Yan Liu (25061)

“…In vitro, experiments showed that semaglutide decreased the expression of S100A9 by activating the Protein Kinase C(PKC) pathway, thus inhibiting ferroptosis in cardiomyocytes.…”

Data Sheet 2_Semaglutide attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis of cardiomyocytes via activation of PKC-S100A9 axis.docx by Yan Liu (25061)

“…In vitro, experiments showed that semaglutide decreased the expression of S100A9 by activating the Protein Kinase C(PKC) pathway, thus inhibiting ferroptosis in cardiomyocytes.…”

Table 1_Semaglutide attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis of cardiomyocytes via activation of PKC-S100A9 axis.docx by Yan Liu (25061)

“…In vitro, experiments showed that semaglutide decreased the expression of S100A9 by activating the Protein Kinase C(PKC) pathway, thus inhibiting ferroptosis in cardiomyocytes.…”

Overall survival of patient with de novo AML in South Korea, from 2011 to 2020 by diagnosis period: (a) age≥ 65 and (b) age <65. by Hyun Jin Han (18592254)

KRAP−/− Mice Showed Decreased Weight-Gain and Decreased Adiposity. by Takahiro Fujimoto (268158)

Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial by José Tarcisio G. Carvalho (4217248)

“…Uremic serum increased the intracellular expression of IL-6, IFN-γ, TLR7, TLR9, VDR, CYP27b1 and CYP24a1. Treatment with 25 or 1,25 vitamin D decreased IL-6 and TLR9. …”

Effect of (HBA:HBD) molar ratio on viscosity and density of ChCl-MEA- 5% water DESs. by Hossam K. Abdrabou (16436541)

Subjects:

DSC Thermogram of neat ChCl-MEA (1:6) DES and with 5% and 10% water content. by Hossam K. Abdrabou (16436541)

Subjects:

F-actin decreases after M64HCl treatment in Caco-2 cells. by Sema Oncel (10152053)

Gal-9 treatment decreases levels of MMP-9, MMP-2 and TIMP-1 but not neutrophil chemoattractants in BALF. by Yuko Horio (4243405)

TFEB nuclear translocation after trehalose treatment in WT COSCs. by Collin M. MacLeod (17512385)

HIV-1 CA mutations selected during passage in rhTRIM5α-expressing cells decrease sensitivity to rhTRIM5α. by Steven J. Soll (270043)

Whole brain FC matrix (comprising of 100 ROI) based on the coherence. by Ishita Rai Bansal (13162713)

Decrease in the relative protein expression of SRBI and LDLR in female apoD−/− mice but opposite pattern for mRNA expression. by Kamilah Ali (680203)

Injection of pNaKtide diminishes PNx-induced decrease in miR-29b-3p expression. by Christopher A. Drummond (3845110)